The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 31, 2017
Filed:
Jun. 20, 2013
Applicant:
Universitaetsklinikum Freiburg, Freiburg, DE;
Inventor:
Georg Bauer, Freiburg, DE;
Assignee:
Universitaetsklinikum Freiburg, Freiburg, DE;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/60 (2006.01); A61K 31/352 (2006.01); C07K 16/40 (2006.01); A61K 31/337 (2006.01); A61K 31/105 (2006.01); A61K 31/05 (2006.01); A61K 31/496 (2006.01); A61K 31/4164 (2006.01); A61K 31/26 (2006.01); A61K 31/198 (2006.01); A61K 31/375 (2006.01); A61K 31/519 (2006.01); A61K 31/10 (2006.01); A61K 31/366 (2006.01); A61K 31/4196 (2006.01); A61K 31/426 (2006.01); A61K 31/427 (2006.01); A61K 31/69 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 31/10 (2013.01); A61K 31/105 (2013.01); A61K 31/198 (2013.01); A61K 31/26 (2013.01); A61K 31/337 (2013.01); A61K 31/352 (2013.01); A61K 31/366 (2013.01); A61K 31/375 (2013.01); A61K 31/4164 (2013.01); A61K 31/4196 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/496 (2013.01); A61K 31/519 (2013.01); A61K 31/60 (2013.01); A61K 31/69 (2013.01); C07K 16/40 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract
The present patent application relates to a pharmaceutical composition, characterized in that it comprises at least one active ingredient which can bring about a singlet oxygen-independent direct catalase inactivation and that the composition further comprises at least one active ingredient that leads to inactivation of catalase as a result of modulation of the nitrogen oxide or superoxide anion metabolism of the cells and subsequent singlet oxygen formation.